Medifast Inc Stock Analysis

MEDIFAST Stock Analysis Notes

About 77.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity recorded a loss per share of 0.64. The firm last dividend was issued on the 18th of September 2023. MEDIFAST INC had 1:20 split on the February 14, 2011. Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people. To find out more about MEDIFAST INC contact Michael MacDonald at 410 581 8042 or learn more at https://medifastinc.com.

MEDIFAST INC Investment Alerts

MEDIFAST INC Upcoming and Recent Events

MEDIFAST Largest EPS Surprises

View All Earnings Estimates

MEDIFAST INC Environmental, Social, and Governance (ESG) Scores

MEDIFAST INC Thematic Classifications

MEDIFAST Stock Institutional Investors

Note, although MEDIFAST INC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MEDIFAST Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 145.52 M.

MEDIFAST Profitablity

The company has Net Profit Margin of (0.01) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.01) %, which entails that for every $100 of revenue, it lost $0.01.

Management Efficiency

MEDIFAST INC has Return on Asset of 0.0133 % which means that on every $100 spent on assets, it made $0.0133 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0332) %, meaning that it generated no profit with money invested by stockholders. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. As of July 19, 2025, Return On Tangible Assets is expected to decline to 0.01. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 10.2 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.

Technical Drivers

As of the 19th of July, MEDIFAST INC secures the mean deviation of 2.2, and Risk Adjusted Performance of 0.032. Compared to fundamental indicators, the technical analysis model lets you check possible technical drivers of MEDIFAST INC, as well as the relationship between them. Please verify MEDIFAST INC coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if MEDIFAST INC is priced fairly, providing market reflects its recent price of 13.24 per share. Given that MEDIFAST INC has jensen alpha of (0.1), we recommend you to check MEDIFAST INC's last-minute market performance to make sure the company can sustain itself in the future.

MEDIFAST INC Price Movement Analysis

MEDIFAST INC Insider Trading Activities

MEDIFAST INC Outstanding Bonds

MEDIFAST INC Predictive Daily Indicators

MEDIFAST INC Corporate Filings

MEDIFAST INC Forecast Models

MEDIFAST INC's time-series forecasting models are one of many MEDIFAST INC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEDIFAST INC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MEDIFAST INC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEDIFAST shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MEDIFAST INC. By using and applying MEDIFAST Stock analysis, traders can create a robust methodology for identifying MEDIFAST entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MEDIFAST analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MEDIFAST analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MEDIFAST INC stock analysis indicators help investors evaluate how MEDIFAST INC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MEDIFAST INC shares will generate the highest return on investment. By understating and applying MEDIFAST INC stock analysis, traders can identify MEDIFAST INC position entry and exit signals to maximize returns.

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.